Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 22nd February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd February 2024,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsverwaltung GmbH 
. The transaction toke place on 22nd February 2024. . The aggregated volume was 449.955,00 EUR, based on an average price of 16,66 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 22nd February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd February 2024,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsverwaltung GmbH . The transaction toke place on 22nd February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 11.795,00 EUR, based on an average price of 16,85 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 22nd February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd February 2024,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsverwaltung GmbH . The transaction toke place on 21st February 2024. . The aggregated volume was 595.000,00 EUR, based on an average price of 17,00 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 12th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 12th June 2023,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsberatung GmbH . The transaction toke place on 8th June 2023. . The aggregated volume was 408.500,00 EUR, based on an average price of 19,00 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 7th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th June 2023,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsberatung GmbH . The transaction toke place on 7th June 2023. The order was executed at the trading place Xetra. . The aggregated volume was 11.190,00 EUR, based on an average price of 18,65 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 7th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th June 2023,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsberatung GmbH . The transaction toke place on 7th June 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 15.120,00 EUR, based on an average price of 18,90 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 7th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th June 2023,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsberatung GmbH . The transaction toke place on 6th June 2023. The order was executed at the trading place Xetra. . The aggregated volume was 76.000,00 EUR, based on an average price of 19,00 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 7th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th June 2023,
The Insider Transaction was made by Dr. Richter Vermögens- und Beteiligungsberatung GmbH . The transaction toke place on 5th June 2023. The order was executed at the trading place Xetra. . The aggregated volume was 7.460,00 EUR, based on an average price of 18,65 EUR. The nature of the Investment was Buy.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 15th February 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 15th February 2023,
The Insider Transaction was made by Hönle, Prof. Dr. Karl . The transaction toke place on 10th February 2023. . The aggregated volume was 400.000,00 EUR, based on an average price of 20,00 EUR. The nature of the Investment was Sell.
Dr. Hönle Aktiengesellschaft: A reportable insider transaction was published on 2nd September 2022. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd September 2022,
The Insider Transaction was made by Hönle, Prof. Dr. Karl . The transaction toke place on 30th August 2022. . The aggregated volume was 440.000,00 EUR, based on an average price of 22,00 EUR. The nature of the Investment was Sell.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 1 | 12th August 2025 | EQS Group AG | EQS |
| Corporate Research | 1 | 12th August 2025 | EQS Group AG | Corporate Research |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.